Coronavirus Vaccine FAQ | Alzheimer's Research Updates
An update on national and local coronavirus vaccine trials, and the latest on Alzheimer's research and therapies.
Segment 1, beginning at 4:33: Coronavirus vaccine trials are making serious progress, but distribution to the public is months or more away.
Pfizer and Moderna's early coronavirus vaccines are respectively 90 and 95% effective at preventing the virus, but life won't go back to normal anytime soon. Dr. Barbara Pahud, part of the team leading the AstraZeneca vaccine trials in Kansas City, says more research needs to be done and that everyone should be prepared to socially distance and wear masks through 2021.
- Dr. Barbara Pahud, Director of Infectious Diseases Research at Children’s Mercy Hospital
Segment 2, beginning at 31:10: The latest in research, therapies and treatments for Alzheimer's disease.
Nine years after Kansas U.S. Rep. Dennis Moore was diagnosed with Alzheimer’s disease, his wife — Stephene Moore — remains a national advocate for those suffering from the condition and their caretakers. Recent medical advances include early detection and the impact of creative arts. Dr. Jeffrey Burns believes early intervention could also soon be on the horizon.
- Dr. Jeffrey Burns, co-director of University of Kansas Alzheimer’s Disease Center
- Stephene Moore, wife of former Kansas Congressman Dennis Moore
More information about the ongoing clinical COVID-19 vaccine trials can be found at CoronavirusPreventionNetwork.org.